Susceptibility to chronic mucus hypersecretion, a genome wide association study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Dijkstra, Akkelies E ^a   Smolonska, Joanna ^a   Van Den Berge, Maarten ^a   Wijmenga, Ciska ^a   Zanen, Pieter ^b   Luinge, Marjan A ^a   Platteel, Mathieu ^a   Lammers, Jan Willem ^b   Dahlback, Magnus ^c   Tosh, Kerrie ^d   Hiemstra, Pieter S ^e   Sterk, Peter J ^f   Spira, Avi ^g   Vestbo, Jorgen ^h,i   Nordestgaard, Borge G ^j,k   Benn, Marianne ^k   Nielsen, Sune F ^j   Dahl, Morten ^j   Verschuren, W Monique ^l   Picavet, H Susan J ^l   Smit, Henriette A ^b   Owsijewitsch, Michael ^m,n   Kauczor, Hans U ^m,n   De Koning, Harry J ^o   Nizankowska Mogilnicka, Eva ^p   Mejza, Filip ^p   Nastalek, Pawel ^p   Van Diemen, Cleo C ^a   Cho, Michael H ^q,r   Silverman, Edwin K ^q,r   Crapo, James D ^s   Beaty, Terri H ^t   Lomas, David A ^u   Bakke, Per ^v   Gulsvik, Amund ^v   Bossé, Yohan ^w   Obeidat, M A ^x   Loth, Daan W ^o,y   Lahousse, Lies ^o,z   Rivadeneira, Fernando ^o,aa   Uitterlinden, Andre G ^a,o   Hofman, Andre ^o,aa   Stricker, Bruno H ^o,y   Brusselle, Guy G ^o,z   Van Duijn, Cornelia M ^o   Brouwer, Uilke ^a   Koppelman, Gerard H ^a,ab   Vonk, Judith M ^a   Nawijn, Martijn C ^a   Groen, Harry J M ^a   Timens, Wim ^a   Boezen, H Marike ^a   Postma, Dirkje S ^a   Alizadeh, B Z ^a   De Boer, R A ^a   Bruinenberg, M ^a   Franke, L ^a   Van Der Harst, P ^a   Hillege, H L ^a   Van Der Klauw, M M ^a   Navis, G ^a   Ormel, J ^a   Rosmalen, Jgm ^a   Slaets, J P ^ac   Snieder, H ^a   Stolk, R P ^a   Wolffenbuttel, Bhr ^a   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ASTRAZENECA R AND D   (Sweden)

^d ASTRAZENECA   (United Kingdom)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

^g BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j Mental Health Services CPH   (Denmark)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

^l NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^m UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

ⁿ German Center for Lung Research (DZL)   (Germany)

^o ERASMUS MEDICAL CENTER   (Netherlands)

^p JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^q BRIGHAM AND WOMEN S HOSPITAL   (United States)

^r HARVARD MEDICAL SCHOOL   (United States)

^s DEPARTMENT OF MEDICINE   (United States)

^t JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v UNIVERSITY OF BERGEN   (Norway)

^w LAVAL UNIVERSITY   (Canada)

^x UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^y Netherlands Health Care Inspectorate   (Netherlands)

^z GHENT UNIVERSITY HOSPITAL   (Belgium)

^aa Netherlands Consortium for Healthy Aging (NCHA)   (Netherlands)

^ab UNIVERSITY OF GRONINGEN   (Netherlands)

^ac Institut Universitaire de Cardiologie et de Pneumologie de Québec Department of Molecular Medicine Laval University ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MATRIX ATTACHMENT REGION BINDING PROTEIN; SATB1 PROTEIN, HUMAN;

ADULT; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CASE CONTROL STUDY; CAUCASIAN; CELL DIFFERENTIATION; CHROMOSOME 3; CHRONIC MUCUS HYPERSECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; INTRON; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PROTEIN INDUCTION; QUANTITATIVE TRAIT LOCUS; RESPIRATORY TRACT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SPECIAL AT RICH SEQUENCE BINDING PROTEIN 1 LOCUS GENE; AGED; CELL CULTURE; CHRONIC DISEASE; GENETICS; LUNG; META ANALYSIS; METABOLISM; MIDDLE AGED; MUCUS; PATHOPHYSIOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; CHRONIC DISEASE; COHORT STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MIDDLE AGED; MUCUS; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84899579701     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091621     Document Type: Article

References (37)

1. Anonymous (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. american thoracic society. Am J Respir Crit Care Med 152: S77-121.
2. Ferre A, Fuhrman C, Zureik M, Chouaid C, Vergnenegre A, et al. (2012) Chronic bronchitis in the general population: Influence of age, gender and socio-economic conditions. Respir Med 106: 467-471.
3. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555. (Pubitemid 47403272)
4. Vestbo J, Rasmussen FV (1989) Respiratory symptoms and FEV1 as predictors of hospitalization and medication in the following 12 years due to respiratory disease. Eur Respir J 2: 710-715.
5. Vestbo J, Prescott E, Lange P (1996) Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. copenhagen city heart study group. Am J Respir Crit Care Med 153: 1530-1535. (Pubitemid 26141336)
6. World Health Organization website. Available: Http://www.who.int/ respiratory/copd/burden/en/index.html. Accessed January 2013.
7. Shurin S (2012) Morbidity & mortality: 2012 chart book on cardiovascular, lung, and blood diseases. 2013: 107.
8. Lange P, Parner J, Prescott E, Vestbo J (2003) Chronic bronchitis in an elderly population. Age Ageing 32: 636-642. (Pubitemid 37461572)
9. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG (2005) Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 6: 98.
10. Viegi G, Carrozzi L, Di Pede F, Baldacci S, Pedreschi M, et al. (1994) Risk factors for chronic obstructive pulmonary disease in a north italian rural area. Eur J Epidemiol 10: 725-731.
11. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, et al. (1998) Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 157: 1770-1778.
12. Hallberg J, Dominicus A, Eriksson UK, Gerhardsson de Verdier M, Pedersen NL, et al. (2008) Interaction between smoking and genetic factors in the development of chronic bronchitis. Am J Respir Crit Care Med 177: 486-490. (Pubitemid 351442186)
13. Zhu G, Agusti A, Gulsvik A, Bakke P, Coxson H, et al. (2009) CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J.
14. Hao K, Bosse Y, Nickle DC, Pare PD, Postma DS, et al. (2012) Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet 8: e1003029.
15. Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, et al. (2009) Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: A randomized trial. Ann Intern Med 151: 517-527.
16. Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, et al. (2011) Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol 6: 1179-1189.
17. Cai S, Lee CC, Kohwi-Shigematsu T (2006) SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes. Nat Genet 38: 1278-1288. (Pubitemid 44646290)
18. Fessing MY, Mardaryev AN, Gdula MR, Sharov AA, Sharova TY, et al. (2011) p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermis. J Cell Biol 194: 825-839.
19. Cai C, Zhang HY, Le JJ, Dong JC, Cui Y, et al. (2010) Inflammatory airway features and hypothalamic-pituitary-adrenal axis function in asthmatic rats combined with chronic obstructive pulmonary disease. Chin Med J (Engl) 123: 1720-1726.
20. Yasui D, Miyano M, Cai S, Varga-Weisz P, Kohwi-Shigematsu T (2002) SATB1 targets chromatin remodelling to regulate genes over long distances. Nature 419: 641-645.
21. Baguma-Nibasheka M, Angka HE, Inanlou MR, Kablar B (2007) Microarray analysis of Myf5 -/-:MyoD-/- hypoplastic mouse lungs reveals a profile of genes involved in pneumocyte differentiation. Histol Histopathol 22: 483-495. (Pubitemid 46647262)
22. Dickinson LA, Joh T, Kohwi Y, Kohwi-Shigematsu T (1992) A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70: 631-645.
23. Krangel MS (2007) T cell development: Better living through chromatin. Nat Immunol 8: 687-694.
24. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, et al. (2009) Management of lung nodules detected by volume CT scanning. N Engl J Med 361: 2221-2229.
25. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, et al. (2011) Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 43: 1082-1090.
26. Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, et al. (2011) The rotterdam study: 2012 objectives and design update. Eur J Epidemiol 26: 657-686.
27. Stolk RP, Rosmalen JG, Postma DS, de Boer RA, Navis G, et al. (2008) Universal risk factors for multifactorial diseases: LifeLines: A three-generation population-based study. Eur J Epidemiol 23: 67-74.
28. Rijcken B, Schouten JP, Mensinga TT, Weiss ST, De Vries K, et al. (1993) Factors associated with bronchial responsiveness to histamine in a population sample of adults. Am Rev Respir Dis 147: 1447-1453. (Pubitemid 23160543)
29. van Diemen CC, Postma DS, Vonk JM, Bruinenberg M, Nolte IM, et al. (2006) Decorin and TGF-beta1 polymorphisms and development of COPD in a general population. Respir Res 7: 89.
30. Verschuren WM, Blokstra A, Picavet HS, Smit HA (2008) Cohort profile: The doetinchem cohort study. Int J Epidemiol 37: 1236-1241.
31. Nizankowska-Mogilnicka E, Mejza F, Buist AS, Vollmer WM, Skucha W, et al. (2007) Prevalence of COPD and tobacco smoking in malopolska region-results from the BOLD study in poland. Pol Arch Med Wewn 117: 402-410. (Pubitemid 350190345)
32. Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, et al. (2011) COPD in never smokers: Results from the population-based burden of obstructive lung disease study. Chest 139: 752-763.
33. Becker N, Delorme S, Kauczor HU (2008) LUSI: The german component of the european trial on the efficacy of multislice-CT for the early detection of lung cancer. onkologie 31.
34. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, et al. (2008) Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 31: 869-873.
35. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, et al. (2010) Genetic epidemiology of COPD (COPDGene) study design. COPD 7: 32-43.
36. Cho MH, Castaldi PJ, Wan ES, Siedlinski M, Hersh CP, et al. (2011) A genomewide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet.
37. Grydeland TB, Dirksen A, Coxson HO, Pillai SG, Sharma S, et al. (2009) Quantitative computed tomography: Emphysema and airway wall thickness by sex, age and smoking. Eur Respir J 34: 858-865.